Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
April 23, 2018
Date of Patent:
September 15, 2020
Assignee:
GENKYOTEX SUISSE SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
Abstract: The present invention is related to amino thiazole derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
December 16, 2015
Date of Patent:
November 20, 2018
Assignee:
GENKYOTEX SUISSE SA
Inventors:
Peter Machin, Andrew Sharpe, Christopher James Lock, Mark S. Chambers, Alastair Hodges, Vivienne Allen, John M. Ellard
Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Type:
Grant
Filed:
June 25, 2015
Date of Patent:
May 22, 2018
Assignee:
GENKYOTEX SUISSE SA
Inventors:
Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini